{"id":12676,"date":"2019-03-22T12:58:34","date_gmt":"2019-03-22T17:58:34","guid":{"rendered":"https:\/\/www.sprim.com\/post\/startups-aim-to-fix-broken-clinical-trials-system\/"},"modified":"2019-03-22T12:58:40","modified_gmt":"2019-03-22T17:58:40","slug":"startups-aim-to-fix-broken-clinical-trials-system","status":"publish","type":"post","link":"https:\/\/www.sprim.com\/pt-br\/post\/startups-aim-to-fix-broken-clinical-trials-system\/","title":{"rendered":"Startups Aim to Fix \u2018Broken\u2019 Clinical Trials System"},"content":{"rendered":"<p><strong>ObvioHealth<\/strong>, meanwhile, has developed an app that enables studies to be run using mobile devices. Data from smart devices such as a Bluetooth blood pressure monitor can integrate with the app, according to the company, which earlier this year raised a $3 million Series A round led by life sciences venture fund <strong>TKS I<\/strong>.<\/p>\n<h3><em>\u201cIf people do not have to drive to a brick-and-mortar study site,\u201d<\/em> said ObvioHealth CEO Bryan Silverman, <em>\u201cyou take away one of the biggest barriers that gets in the way of recruitment.\u201d<\/em><\/h3>\n<p><a class=\"button\" href=\"https:\/\/www.wsj.com\/articles\/startups-aim-to-fix-broken-clinical-trials-system-1539338401\" target=\"_blank\" rel=\"noopener\">Read the Full News Article<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>ObvioHealth, meanwhile, has developed an app that enables studies to be run using mobile devices. Data from smart devices such as a Bluetooth blood pressure monitor can integrate with the app, according to the company, which earlier this year raised &#8230; <a class=\"read-more\" href=\"https:\/\/www.sprim.com\/pt-br\/post\/startups-aim-to-fix-broken-clinical-trials-system\/\">Read More&nbsp;<i class=\"fas fa-angle-double-right\" style=\"display: inline\"><\/i><\/a><\/p>\n","protected":false},"author":17,"featured_media":11839,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_relevanssi_hide_post":"","_relevanssi_hide_content":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"","_relevanssi_noindex_reason":""},"categories":[301,303],"tags":[],"acf":[],"_links":{"self":[{"href":"https:\/\/www.sprim.com\/pt-br\/wp-json\/wp\/v2\/posts\/12676"}],"collection":[{"href":"https:\/\/www.sprim.com\/pt-br\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.sprim.com\/pt-br\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.sprim.com\/pt-br\/wp-json\/wp\/v2\/users\/17"}],"replies":[{"embeddable":true,"href":"https:\/\/www.sprim.com\/pt-br\/wp-json\/wp\/v2\/comments?post=12676"}],"version-history":[{"count":0,"href":"https:\/\/www.sprim.com\/pt-br\/wp-json\/wp\/v2\/posts\/12676\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.sprim.com\/pt-br\/wp-json\/wp\/v2\/media\/11839"}],"wp:attachment":[{"href":"https:\/\/www.sprim.com\/pt-br\/wp-json\/wp\/v2\/media?parent=12676"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.sprim.com\/pt-br\/wp-json\/wp\/v2\/categories?post=12676"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.sprim.com\/pt-br\/wp-json\/wp\/v2\/tags?post=12676"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}